HJ Research delivers in-depth insights on the global Next Generation Sequencing (NGS) market in its upcoming report titled, Global Next Generation Sequencing (NGS) Market Report 2018-2029. According to this study, the global Next Generation Sequencing (NGS) market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Next Generation Sequencing (NGS) market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Next Generation Sequencing (NGS) market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Next Generation Sequencing (NGS) industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Next Generation Sequencing (NGS) industry.
Global Next Generation Sequencing (NGS) market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Next Generation Sequencing (NGS) industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Next Generation Sequencing (NGS) market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Next Generation Sequencing (NGS). The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Next Generation Sequencing (NGS) market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Next Generation Sequencing (NGS) in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Next Generation Sequencing (NGS) market include:
Illumina
Thermo Fisher Scientific
Pacific Biosciences of California
Beijing Genomics Institute
Qiagen
Roche
Agilent Technologies
Perkinelmer
Genomatix
PierianDx
Eurofins Scientific
Gatc Biotech
Oxford Nanopore Technologies
Bio-Rad Laboratories
DNASTAR
Biomatters
Partek
New England Biolabs
Myriad Genetics
Macrogen
GATC Biotech
Market segmentation, by product types:
Consumables
Platforms
Services
Market segmentation, by applications:
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
1 Industry Overview of Next Generation Sequencing (NGS)
1.1 Research Scope
1.2 Market Segmentation by Types of Next Generation Sequencing (NGS)
1.3 Market Segmentation by End Users of Next Generation Sequencing (NGS)
1.4 Market Dynamics Analysis of Next Generation Sequencing (NGS)
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Next Generation Sequencing (NGS) Industry
2.1 Illumina
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Thermo Fisher Scientific
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Pacific Biosciences of California
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Beijing Genomics Institute
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Qiagen
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Roche
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Agilent Technologies
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Perkinelmer
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Genomatix
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 PierianDx
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
2.11 Eurofins Scientific
2.11.1 Company Overview
2.11.2 Main Products and Specifications
2.11.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.11.4 Contact Information
2.12 Gatc Biotech
2.12.1 Company Overview
2.12.2 Main Products and Specifications
2.12.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.12.4 Contact Information
2.13 Oxford Nanopore Technologies
2.13.1 Company Overview
2.13.2 Main Products and Specifications
2.13.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.13.4 Contact Information
2.14 Bio-Rad Laboratories
2.14.1 Company Overview
2.14.2 Main Products and Specifications
2.14.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.14.4 Contact Information
2.15 DNASTAR
2.15.1 Company Overview
2.15.2 Main Products and Specifications
2.15.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.15.4 Contact Information
2.16 Biomatters
2.16.1 Company Overview
2.16.2 Main Products and Specifications
2.16.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.16.4 Contact Information
2.17 Partek
2.17.1 Company Overview
2.17.2 Main Products and Specifications
2.17.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.17.4 Contact Information
2.18 New England Biolabs
2.18.1 Company Overview
2.18.2 Main Products and Specifications
2.18.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.18.4 Contact Information
2.19 Myriad Genetics
2.19.1 Company Overview
2.19.2 Main Products and Specifications
2.19.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.19.4 Contact Information
2.20 Macrogen
2.20.1 Company Overview
2.20.2 Main Products and Specifications
2.20.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.20.4 Contact Information
2.21 GATC Biotech
2.21.1 Company Overview
2.21.2 Main Products and Specifications
2.21.3 Next Generation Sequencing (NGS) Revenue and Gross Margin (2018-2023)
2.21.4 Contact Information
3 Global Next Generation Sequencing (NGS) Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Next Generation Sequencing (NGS) by Regions (2018-2023)
3.2 Global Sales Revenue of Next Generation Sequencing (NGS) by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Next Generation Sequencing (NGS) by Types (2018-2023)
3.4 Global Sales Revenue of Next Generation Sequencing (NGS) by End Users (2018-2023)
4 Northern America Next Generation Sequencing (NGS) Market Analysis by Countries, Types and End Users
4.1 Northern America Next Generation Sequencing (NGS) Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Next Generation Sequencing (NGS) Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Next Generation Sequencing (NGS) Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
4.5 Canada Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
5 Europe Next Generation Sequencing (NGS) Market Analysis by Countries, Types and End Users
5.1 Europe Next Generation Sequencing (NGS) Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Next Generation Sequencing (NGS) Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Next Generation Sequencing (NGS) Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
5.5 France Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
5.6 UK Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
5.7 Italy Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
5.8 Russia Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
5.9 Spain Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
5.10 Netherlands Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
6 Asia Pacific Next Generation Sequencing (NGS) Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Next Generation Sequencing (NGS) Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Next Generation Sequencing (NGS) Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Next Generation Sequencing (NGS) Sales Revenue Analysis by End Users (2018-2023)
6.4 China Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
6.5 Japan Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
6.6 Korea Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
6.7 India Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
6.8 Australia Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
6.9 Indonesia Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
6.10 Vietnam Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
7 Latin America Next Generation Sequencing (NGS) Market Analysis by Countries, Types and End Users
7.1 Latin America Next Generation Sequencing (NGS) Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Next Generation Sequencing (NGS) Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Next Generation Sequencing (NGS) Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
7.5 Mexico Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
7.6 Argentina Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
7.7 Colombia Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Next Generation Sequencing (NGS) Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Next Generation Sequencing (NGS) Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Next Generation Sequencing (NGS) Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Next Generation Sequencing (NGS) Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
8.6 South Africa Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
8.7 Egypt Next Generation Sequencing (NGS) Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Next Generation Sequencing (NGS) Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Next Generation Sequencing (NGS) by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Next Generation Sequencing (NGS) by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Next Generation Sequencing (NGS) by End Users (2024-2029)
10.4 Global Revenue Forecast of Next Generation Sequencing (NGS) by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Next Generation Sequencing (NGS)
11.1 Upstream Analysis of Next Generation Sequencing (NGS)
11.2 Downstream Major Consumers Analysis of Next Generation Sequencing (NGS)
11.3 Major Suppliers of Next Generation Sequencing (NGS) with Contact Information
11.4 Supply Chain Relationship Analysis of Next Generation Sequencing (NGS)
12 Next Generation Sequencing (NGS) New Project Investment Feasibility Analysis
12.1 Next Generation Sequencing (NGS) New Project SWOT Analysis
12.2 Next Generation Sequencing (NGS) New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Next Generation Sequencing (NGS) Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Next Generation Sequencing (NGS)
Table End Users of Next Generation Sequencing (NGS)
Figure Market Drivers Analysis of Next Generation Sequencing (NGS)
Figure Market Challenges Analysis of Next Generation Sequencing (NGS)
Figure Market Opportunities Analysis of Next Generation Sequencing (NGS)
Table Market Drivers Analysis of Next Generation Sequencing (NGS)
Table Illumina Information List
Figure Next Generation Sequencing (NGS) Specifications of Illumina
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Illumina (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Illumina (2018-2023)
Table Thermo Fisher Scientific Information List
Figure Next Generation Sequencing (NGS) Specifications of Thermo Fisher Scientific
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Thermo Fisher Scientific (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Thermo Fisher Scientific (2018-2023)
Table Pacific Biosciences of California Information List
Figure Next Generation Sequencing (NGS) Specifications of Pacific Biosciences of California
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Pacific Biosciences of California (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Pacific Biosciences of California (2018-2023)
Table Beijing Genomics Institute Information List
Figure Next Generation Sequencing (NGS) Specifications of Beijing Genomics Institute
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Beijing Genomics Institute (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Beijing Genomics Institute (2018-2023)
Table Qiagen Information List
Figure Next Generation Sequencing (NGS) Specifications of Qiagen
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Qiagen (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Qiagen (2018-2023)
Table Roche Information List
Figure Next Generation Sequencing (NGS) Specifications of Roche
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Roche (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Roche (2018-2023)
Table Agilent Technologies Information List
Figure Next Generation Sequencing (NGS) Specifications of Agilent Technologies
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Agilent Technologies (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Agilent Technologies (2018-2023)
Table Perkinelmer Information List
Figure Next Generation Sequencing (NGS) Specifications of Perkinelmer
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Perkinelmer (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Perkinelmer (2018-2023)
Table Genomatix Information List
Figure Next Generation Sequencing (NGS) Specifications of Genomatix
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Genomatix (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Genomatix (2018-2023)
Table PierianDx Information List
Figure Next Generation Sequencing (NGS) Specifications of PierianDx
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of PierianDx (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of PierianDx (2018-2023)
Table Eurofins Scientific Information List
Figure Next Generation Sequencing (NGS) Specifications of Eurofins Scientific
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Eurofins Scientific (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Eurofins Scientific (2018-2023)
Table Gatc Biotech Information List
Figure Next Generation Sequencing (NGS) Specifications of Gatc Biotech
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Gatc Biotech (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Gatc Biotech (2018-2023)
Table Oxford Nanopore Technologies Information List
Figure Next Generation Sequencing (NGS) Specifications of Oxford Nanopore Technologies
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Oxford Nanopore Technologies (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Oxford Nanopore Technologies (2018-2023)
Table Bio-Rad Laboratories Information List
Figure Next Generation Sequencing (NGS) Specifications of Bio-Rad Laboratories
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Bio-Rad Laboratories (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Bio-Rad Laboratories (2018-2023)
Table DNASTAR Information List
Figure Next Generation Sequencing (NGS) Specifications of DNASTAR
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of DNASTAR (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of DNASTAR (2018-2023)
Table Biomatters Information List
Figure Next Generation Sequencing (NGS) Specifications of Biomatters
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Biomatters (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Biomatters (2018-2023)
Table Partek Information List
Figure Next Generation Sequencing (NGS) Specifications of Partek
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Partek (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Partek (2018-2023)
Table New England Biolabs Information List
Figure Next Generation Sequencing (NGS) Specifications of New England Biolabs
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of New England Biolabs (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of New England Biolabs (2018-2023)
Table Myriad Genetics Information List
Figure Next Generation Sequencing (NGS) Specifications of Myriad Genetics
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Myriad Genetics (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Myriad Genetics (2018-2023)
Table Macrogen Information List
Figure Next Generation Sequencing (NGS) Specifications of Macrogen
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of Macrogen (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of Macrogen (2018-2023)
Table GATC Biotech Information List
Figure Next Generation Sequencing (NGS) Specifications of GATC Biotech
Table Next Generation Sequencing (NGS) Revenue (Million USD) and Gross Margin of GATC Biotech (2018-2023)
Figure Next Generation Sequencing (NGS) Revenue (Million USD) and Global Market Share of GATC Biotech (2018-2023)
Table Global Revenue (Million USD) of Next Generation Sequencing (NGS) by Regions (2018-2023)
Table Global Revenue (Million USD) of Next Generation Sequencing (NGS) by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Next Generation Sequencing (NGS) by Types (2018-2023)
Table Global Revenue (Million USD) of Next Generation Sequencing (NGS) by End Users (2018-2023)
Table Northern America Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2018-2023)
Table Northern America Next Generation Sequencing (NGS) Revenue (Million USD) by Types (2018-2023)
Table Northern America Next Generation Sequencing (NGS) Revenue (Million USD) by End Users (2018-2023)
Figure United States Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2018-2023)
Table Europe Next Generation Sequencing (NGS) Revenue (Million USD) by Types (2018-2023)
Table Europe Next Generation Sequencing (NGS) Revenue (Million USD) by End Users (2018-2023)
Figure Germany Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Next Generation Sequencing (NGS) Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Next Generation Sequencing (NGS) Revenue (Million USD) by End Users (2018-2023)
Figure China Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2018-2023)
Table Latin America Next Generation Sequencing (NGS) Revenue (Million USD) by Types (2018-2023)
Table Latin America Next Generation Sequencing (NGS) Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Next Generation Sequencing (NGS) Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Next Generation Sequencing (NGS) Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Next Generation Sequencing (NGS) by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Next Generation Sequencing (NGS) by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Next Generation Sequencing (NGS) by End Users (2024-2029)
Table Major Consumers with Contact Information of Next Generation Sequencing (NGS)
Table Major Suppliers of Next Generation Sequencing (NGS) with Contact Information
Figure Supply Chain Relationship Analysis of Next Generation Sequencing (NGS)
Table New Project SWOT Analysis of Next Generation Sequencing (NGS)
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Next Generation Sequencing (NGS)
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Next Generation Sequencing (NGS) Industry
Table Part of References List of Next Generation Sequencing (NGS) Industry
Table Units of Measurement List
Table Part of Author Details List of Next Generation Sequencing (NGS) Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Next Generation Sequencing (NGS) industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Next Generation Sequencing (NGS) market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Next Generation Sequencing (NGS) manufacturers, Next Generation Sequencing (NGS) raw material suppliers, Next Generation Sequencing (NGS) distributors as well as buyers. The primary sources from the supply side include Next Generation Sequencing (NGS) manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Next Generation Sequencing (NGS) raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Next Generation Sequencing (NGS) industry landscape and trends, Next Generation Sequencing (NGS) market dynamics and key issues, Next Generation Sequencing (NGS) technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Next Generation Sequencing (NGS) competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Next Generation Sequencing (NGS) market size and forecast by regions, Next Generation Sequencing (NGS) market size and forecast by application, Next Generation Sequencing (NGS) market size and forecast by types, Next Generation Sequencing (NGS) company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
